SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3j97'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EQB_A_FFOA1293_2 (SERINE HYDROXYMETHYLTRANSFE RASE)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	3 / 3	SER H 157 GLU H 156 GLU H 155	None	0.34A	1eqbD-3j97H: undetectable	1eqbD-3j97H: 21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EQB_C_FFOC3293_0 (SERINE HYDROXYMETHYLTRANSFE RASE)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	3 / 3	SER H 157 GLU H 156 GLU H 155	None	0.34A	1eqbB-3j97H: undetectable	1eqbB-3j97H: 21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GTN_L_TRPL81_0 (TRP RNA-BINDING ATTENUATION PROTEIN)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 9	VAL A 391 GLY A 255 ALA A 234 ILE A 256 SER A 237	None	1.32A	1gtnL-3j97A: undetectable 1gtnM-3j97A: undetectable	1gtnL-3j97A: 7.26 1gtnM-3j97A: 7.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1IWH_A_PEMA501_1 (HEMOGLOBIN ALPHA CHAIN)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 6	ALA A 584 LYS A 587 ASP A 591 ALA A 592 LEU A 640	None	1.28A	1iwhA-3j97A: undetectable	1iwhA-3j97A: 12.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JU6_A_LYAA317_1 (THYMIDYLATE SYNTHASE)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 11	PHE A 125 ASN A 180 LEU A 176 GLY A 175 PHE A 130	None	1.29A	1ju6A-3j97A: undetectable	1ju6A-3j97A: 16.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KT7_A_RTLA184_0 (PLASMA RETINOL-BINDING PROTEIN)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 11	LEU A 608 ALA A 580 VAL A 602 MET A 585 LEU A 629	None	1.37A	1kt7A-3j97A: undetectable	1kt7A-3j97A: 12.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RTS_A_D16A309_1 (THYMIDYLATE SYNTHASE)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	4 / 8	PHE A 140 LEU A 147 GLY A 146 PHE A 145	None	0.68A	1rtsA-3j97A: undetectable	1rtsA-3j97A: 17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UDU_A_CIAA1003_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 11	VAL A 60 ALA A 61 PHE A 62 LEU A 72 ILE A 74	None	1.28A	1uduA-3j97A: undetectable	1uduA-3j97A: 19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_C_CHDC3525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	1v54A-3j97H: 2.9 1v54C-3j97H: 5.0	1v54A-3j97H: 19.26 1v54C-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_P_CHDP4525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.22A	1v54N-3j97H: 2.8 1v54P-3j97H: 5.0	1v54N-3j97H: 19.26 1v54P-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V55_C_CHDC3525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	1v55A-3j97H: 2.8 1v55C-3j97H: 5.0	1v55A-3j97H: 19.26 1v55C-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WOP_A_FFOA2888_0 (AMINOMETHYLTRANSFERA SE)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 10	LEU A 541 LEU A 552 ILE A 665 GLU A 522 LEU A 518	None	1.25A	1wopA-3j97A: undetectable	1wopA-3j97A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	2dyrA-3j97H: 2.8 2dyrC-3j97H: 5.1	2dyrA-3j97H: 19.26 2dyrC-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	2dyrN-3j97H: 2.8 2dyrP-3j97H: 5.0	2dyrN-3j97H: 19.26 2dyrP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_C_CHDC304_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.25A	2dysA-3j97H: 2.7 2dysC-3j97H: 5.1	2dysA-3j97H: 19.26 2dysC-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_P_CHDP304_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.22A	2dysN-3j97H: 2.7 2dysP-3j97H: 5.1	2dysN-3j97H: 19.26 2dysP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	2eijA-3j97H: 2.8 2eijC-3j97H: 5.0	2eijA-3j97H: 19.26 2eijC-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	2eijN-3j97H: 2.8 2eijP-3j97H: 5.0	2eijN-3j97H: 19.26 2eijP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.27A	2eikA-3j97H: undetectable 2eikC-3j97H: 5.0	2eikA-3j97H: 19.26 2eikC-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.23A	2eikN-3j97H: 2.8 2eikP-3j97H: 5.0	2eikN-3j97H: 19.26 2eikP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	2eilA-3j97H: 2.7 2eilC-3j97H: 5.0	2eilA-3j97H: 19.26 2eilC-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.23A	2eilN-3j97H: 2.8 2eilP-3j97H: 5.0	2eilN-3j97H: 19.26 2eilP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_A_CHDA525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.25A	2eimA-3j97H: 3.4 2eimC-3j97H: 5.1	2eimA-3j97H: 19.26 2eimC-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.30A	2eimN-3j97H: 3.2 2eimP-3j97H: 5.0	2eimN-3j97H: 19.26 2eimP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	2einA-3j97H: 2.4 2einC-3j97H: 5.0	2einA-3j97H: 19.26 2einC-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.28A	2einN-3j97H: 2.8 2einP-3j97H: 5.1	2einN-3j97H: 19.26 2einP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2P2F_B_ACTB653_0 (ACETYL-COENZYME A SYNTHETASE)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	4 / 4	VAL A 350 THR A 349 VAL A 295 GLY A 296	None	1.12A	2p2fB-3j97A: undetectable	2p2fB-3j97A: 21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QEU_A_ACTA141_0 (PUTATIVE CARBOXYMUCONOLACTONE DECARBOXYLASE)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	3 / 3	VAL H 256 ASP H 257 GLU H 291	None	0.50A	2qeuA-3j97H: 3.5	2qeuA-3j97H: 19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QEU_C_ACTC141_0 (PUTATIVE CARBOXYMUCONOLACTONE DECARBOXYLASE)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	3 / 3	VAL H 256 ASP H 257 GLU H 291	None	0.52A	2qeuC-3j97H: 3.5	2qeuC-3j97H: 19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X91_A_LPRA1615_2 (ANGIOTENSIN CONVERTING ENZYME)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	3 / 3	SER A 569 THR A 550 PHE A 661	None	0.74A	2x91A-3j97A: undetectable	2x91A-3j97A: 21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XZ5_C_ACHC1210_0 (SOLUBLE ACETYLCHOLINE RECEPTOR)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	4 / 8	ILE A 643 TYR A 502 VAL A 602 CYH A 599	None	1.18A	2xz5A-3j97A: undetectable 2xz5C-3j97A: undetectable	2xz5A-3j97A: 14.13 2xz5C-3j97A: 14.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XZ5_D_ACHD1210_0 (SOLUBLE ACETYLCHOLINE RECEPTOR)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	4 / 8	ILE A 643 TYR A 502 VAL A 602 CYH A 599	None	1.17A	2xz5C-3j97A: undetectable 2xz5D-3j97A: undetectable	2xz5C-3j97A: 14.13 2xz5D-3j97A: 14.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XZ5_E_ACHE1210_0 (SOLUBLE ACETYLCHOLINE RECEPTOR)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	4 / 7	ILE A 643 TYR A 502 VAL A 602 CYH A 599	None	1.19A	2xz5D-3j97A: undetectable 2xz5E-3j97A: undetectable	2xz5D-3j97A: 14.13 2xz5E-3j97A: 14.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XZ5_E_ACHE1211_0 (SOLUBLE ACETYLCHOLINE RECEPTOR)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	ILE H 125 SER H 157 TYR H 151 CYH H 164	None	1.29A	2xz5D-3j97H: undetectable 2xz5E-3j97H: undetectable	2xz5D-3j97H: 21.23 2xz5E-3j97H: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y69_A_CHDA1517_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	2y69A-3j97H: 2.8 2y69C-3j97H: 5.1	2y69A-3j97H: 19.26 2y69C-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.21A	2zxwA-3j97H: 2.8 2zxwC-3j97H: 5.0	2zxwA-3j97H: 19.26 2zxwC-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.22A	2zxwN-3j97H: 3.7 2zxwP-3j97H: 5.0	2zxwN-3j97H: 19.26 2zxwP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABK_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.23A	3abkA-3j97H: 2.9 3abkC-3j97H: 5.0	3abkA-3j97H: 19.26 3abkC-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABK_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.27A	3abkN-3j97H: 2.3 3abkP-3j97H: 5.0	3abkN-3j97H: 19.26 3abkP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.22A	3abmN-3j97H: 2.9 3abmP-3j97H: 5.0	3abmN-3j97H: 19.26 3abmP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG1_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.27A	3ag1A-3j97H: 3.2 3ag1C-3j97H: 4.9	3ag1A-3j97H: 19.26 3ag1C-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG1_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.26A	3ag1N-3j97H: 2.7 3ag1P-3j97H: 5.0	3ag1N-3j97H: 19.26 3ag1P-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_A_CHDA525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.26A	3ag2A-3j97H: 2.8 3ag2C-3j97H: 5.0	3ag2A-3j97H: 19.26 3ag2C-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.25A	3ag2N-3j97H: 3.4 3ag2P-3j97H: 5.0	3ag2N-3j97H: 19.26 3ag2P-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.28A	3ag3A-3j97H: 3.3 3ag3C-3j97H: 5.0	3ag3A-3j97H: 19.26 3ag3C-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	3ag3N-3j97H: 2.8 3ag3P-3j97H: 5.0	3ag3N-3j97H: 19.26 3ag3P-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.26A	3ag4A-3j97H: undetectable 3ag4C-3j97H: 5.0	3ag4A-3j97H: 19.26 3ag4C-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.28A	3ag4N-3j97H: 2.8 3ag4P-3j97H: 5.0	3ag4N-3j97H: 19.26 3ag4P-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.26A	3asnA-3j97H: 2.9 3asnC-3j97H: 5.0	3asnA-3j97H: 19.26 3asnC-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DXY_A_SAMA1_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	5 / 11	GLU H 186 GLY H 189 ILE H 184 ALA H 169 ASP H 204	None	0.97A	3dxyA-3j97H: undetectable	3dxyA-3j97H: 20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3J6G_B_TA1B502_1 (TUBULIN BETA CHAIN)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 10	ASP A 14 LEU A 136 SER A 139 PHE A 125 THR A 48	None	1.49A	3j6gB-3j97A: undetectable	3j6gB-3j97A: 20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3J6G_D_TA1D502_1 (TUBULIN BETA CHAIN)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 10	ASP A 14 LEU A 136 SER A 139 PHE A 125 THR A 48	None	1.49A	3j6gD-3j97A: undetectable	3j6gD-3j97A: 20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3J6G_F_TA1F502_1 (TUBULIN BETA CHAIN)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 10	ASP A 14 LEU A 136 SER A 139 PHE A 125 THR A 48	None	1.49A	3j6gF-3j97A: undetectable	3j6gF-3j97A: 20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3J6G_H_TA1H502_1 (TUBULIN BETA CHAIN)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 10	ASP A 14 LEU A 136 SER A 139 PHE A 125 THR A 48	None	1.49A	3j6gH-3j97A: 1.3	3j6gH-3j97A: 20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3J6G_J_TA1J502_1 (TUBULIN BETA CHAIN)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 10	ASP A 14 LEU A 136 SER A 139 PHE A 125 THR A 48	None	1.49A	3j6gJ-3j97A: 1.8	3j6gJ-3j97A: 20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3J6G_L_TA1L502_1 (TUBULIN BETA CHAIN)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 10	ASP A 14 LEU A 136 SER A 139 PHE A 125 THR A 48	None	1.49A	3j6gL-3j97A: 1.2	3j6gL-3j97A: 20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3J6G_N_TA1N502_1 (TUBULIN BETA CHAIN)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 10	ASP A 14 LEU A 136 SER A 139 PHE A 125 THR A 48	None	1.49A	3j6gN-3j97A: undetectable	3j6gN-3j97A: 20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3J6G_P_TA1P502_1 (TUBULIN BETA CHAIN)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 10	ASP A 14 LEU A 136 SER A 139 PHE A 125 THR A 48	None	1.49A	3j6gP-3j97A: 1.2	3j6gP-3j97A: 20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3J6G_R_TA1R502_1 (TUBULIN BETA CHAIN)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 10	ASP A 14 LEU A 136 SER A 139 PHE A 125 THR A 48	None	1.49A	3j6gR-3j97A: undetectable	3j6gR-3j97A: 20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KK6_A_CELA701_2 (PROSTAGLANDIN G/H SYNTHASE 1)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	4 / 6	VAL A 514 LEU A 641 ILE A 567 LEU A 518	None	0.72A	3kk6A-3j97A: undetectable	3kk6A-3j97A: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3L35_H_DHIH3_0 (GP41 N-PEPTIDE HIV ENTRY INHIBITOR PIE12)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	3 / 3	LEU A 710 TRP A 510 GLY A 511	None	0.76A	3l35A-3j97A: undetectable 3l35H-3j97A: undetectable	3l35A-3j97A: 5.50 3l35H-3j97A: 1.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3L35_K_DHIK3_0 (GP41 N-PEPTIDE HIV ENTRY INHIBITOR PIE12)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	3 / 3	LEU A 710 TRP A 510 GLY A 511	None	0.81A	3l35B-3j97A: undetectable 3l35K-3j97A: undetectable	3l35B-3j97A: 5.50 3l35K-3j97A: 1.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WG7_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 8	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.23A	3wg7C-3j97H: 5.0 3wg7N-3j97H: 2.8 3wg7P-3j97H: 5.0	3wg7C-3j97H: 19.54 3wg7N-3j97H: 19.26 3wg7P-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ECK_B_FOLB703_0 (BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLAT E SYNTHASE)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 12	ASP A 328 PHE A 327 LEU A 354 VAL A 369 THR A 267	None	0.91A	4eckB-3j97A: undetectable	4eckB-3j97A: 23.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IAR_A_ERMA2001_2 (CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 1B AND E. COLI SOLUBLE CYTOCHROME B562)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	4 / 7	THR A 534 VAL A 628 SER A 662 ASP A 590	None	1.29A	4iarA-3j97A: undetectable	4iarA-3j97A: 20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.23A	5b1aN-3j97H: 2.8 5b1aP-3j97H: 5.0	5b1aN-3j97H: 19.26 5b1aP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.25A	5b1bN-3j97H: 3.6 5b1bP-3j97H: 5.1	5b1bN-3j97H: 19.26 5b1bP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	5b3sN-3j97H: 2.8 5b3sP-3j97H: 5.0	5b3sN-3j97H: 19.26 5b3sP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H3A_B_D16B401_1 (ORF70)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	4 / 7	PHE A 140 LEU A 147 GLY A 146 PHE A 145	None	0.64A	5h3aB-3j97A: undetectable	5h3aB-3j97A: 16.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IY5_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.20A	5iy5A-3j97H: 2.8 5iy5C-3j97H: 5.0	5iy5A-3j97H: 19.26 5iy5C-3j97H: 18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J4N_B_AG2B501_1 (ARGININE/AGMATINE ANTIPORTER)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	ILE H 125 GLY H 89 ASN H 90 ILE H 127	None	0.95A	5j4nB-3j97H: undetectable	5j4nB-3j97H: 19.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KOC_A_SAMA401_0 (PAVINE N-METHYLTRANSFERASE)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 12	GLY A 543 VAL A 517 THR A 515 ALA A 551 LEU A 552	None	1.04A	5kocA-3j97A: 2.2	5kocA-3j97A: 20.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NVP_A_ACAA18_1 (ENVELOPE GLYCOPROTEIN,GP41)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	5 / 12	SER H 238 LYS H 242 LYS H 203 GLU H 229 GLU H 230	None	1.45A	5nvpA-3j97H: 0.0	5nvpA-3j97H: 7.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TZO_B_7V7B201_1 (ENDO-1,4-BETA-XYLANA SE A)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	5 / 12	LEU A 16 SER A 25 VAL A 23 ALA A 9 ALA A 61	None	1.16A	5tzoB-3j97A: undetectable	5tzoB-3j97A: 12.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X19_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	5x19N-3j97H: 0.7 5x19P-3j97H: 4.9	5x19N-3j97H: 19.26 5x19P-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1B_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.21A	5x1bN-3j97H: 2.7 5x1bP-3j97H: 4.8	5x1bN-3j97H: 19.26 5x1bP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1F_P_CHDP305_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.25A	5x1fN-3j97H: 2.8 5x1fP-3j97H: 4.9	5x1fN-3j97H: 19.26 5x1fP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X5Q_C_D16C402_1 (THYMIDYLATE SYNTHASE)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	4 / 7	PHE A 140 LEU A 147 GLY A 146 PHE A 145	None	0.62A	5x5qC-3j97A: undetectable	5x5qC-3j97A: 17.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X5Q_D_D16D402_1 (THYMIDYLATE SYNTHASE)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	4 / 8	PHE A 140 LEU A 147 GLY A 146 PHE A 145	None	0.64A	5x5qD-3j97A: undetectable	5x5qD-3j97A: 17.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X5Q_F_D16F402_1 (THYMIDYLATE SYNTHASE)	3j97	VESICLE-FUSING ATPASE (Cricetulus griseus)	4 / 8	PHE A 140 LEU A 147 GLY A 146 PHE A 145	None	0.63A	5x5qF-3j97A: undetectable	5x5qF-3j97A: 17.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z84_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 8	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.22A	5z84A-3j97H: 2.8 5z84C-3j97H: 5.1 5z84P-3j97H: 5.1	5z84A-3j97H: 19.26 5z84C-3j97H: 19.54 5z84P-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z84_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.22A	5z84C-3j97H: 5.1 5z84N-3j97H: 2.8 5z84P-3j97H: 5.1	5z84C-3j97H: 19.54 5z84N-3j97H: 19.26 5z84P-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z85_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	5z85C-3j97H: 5.0 5z85N-3j97H: 2.9 5z85P-3j97H: 5.1	5z85C-3j97H: 19.54 5z85N-3j97H: 19.26 5z85P-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCO_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 8	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.23A	5zcoA-3j97H: 2.8 5zcoC-3j97H: 5.1 5zcoP-3j97H: 5.1	5zcoA-3j97H: 19.26 5zcoC-3j97H: 19.54 5zcoP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCQ_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.23A	5zcqN-3j97H: 2.8 5zcqP-3j97H: 5.1	5zcqN-3j97H: 19.26 5zcqP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN4_B_AM2B301_0 (AMINOGLYCOSIDE N(3)-ACETYLTRANSFERA SE, AAC(3)-IVA)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 8	ASP H 80 HIS H 123 HIS H 72 ASP H 87	None	1.11A	6mn4B-3j97H: undetectable	6mn4B-3j97H: 20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN4_C_AM2C301_0 (AMINOGLYCOSIDE N(3)-ACETYLTRANSFERA SE, AAC(3)-IVA)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 8	ASP H 80 HIS H 123 HIS H 72 ASP H 87	None	1.07A	6mn4C-3j97H: undetectable	6mn4C-3j97H: 20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NKN_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.23A	6nknA-3j97H: 2.9 6nknC-3j97H: 4.8	6nknA-3j97H: 19.26 6nknC-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMF_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	6nmfN-3j97H: undetectable 6nmfP-3j97H: 4.9	6nmfN-3j97H: 19.26 6nmfP-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_C_CHDC303_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 6	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.21A	6nmpA-3j97H: 2.8 6nmpC-3j97H: 4.8	6nmpA-3j97H: 19.26 6nmpC-3j97H: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_P_CHDP302_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3j97	ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (Rattus norvegicus)	4 / 7	HIS H 124 ASP H 113 THR H 112 HIS H 144	None	1.24A	6nmpN-3j97H: 1.6 6nmpP-3j97H: 5.0	6nmpN-3j97H: 19.26 6nmpP-3j97H: 19.54

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1EQB_A_FFOA1293_2","SERINE HYDROXYMETHYLTRANSFERASE","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",3,"SER H 157;GLU H 156;GLU H 155","None","0.34A","1eqbD-3j97H:undetectable","1eqbD-3j97H:21.06"],["1EQB_C_FFOC3293_0","SERINE HYDROXYMETHYLTRANSFERASE","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",3,"SER H 157;GLU H 156;GLU H 155","None","0.34A","1eqbB-3j97H:undetectable","1eqbB-3j97H:21.06"],["1GTN_L_TRPL81_0","TRP RNA-BINDING ATTENUATION PROTEIN","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"VAL A 391;GLY A 255;ALA A 234;ILE A 256;SER A 237","None","1.32A","1gtnL-3j97A:undetectable;1gtnM-3j97A:undetectable","1gtnL-3j97A:7.26;1gtnM-3j97A:7.26"],["1IWH_A_PEMA501_1","HEMOGLOBIN ALPHA CHAIN","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"ALA A 584;LYS A 587;ASP A 591;ALA A 592;LEU A 640","None","1.28A","1iwhA-3j97A:undetectable","1iwhA-3j97A:12.80"],["1JU6_A_LYAA317_1","THYMIDYLATE SYNTHASE","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"PHE A 125;ASN A 180;LEU A 176;GLY A 175;PHE A 130","None","1.29A","1ju6A-3j97A:undetectable","1ju6A-3j97A:16.96"],["1KT7_A_RTLA184_0","PLASMA RETINOL-BINDING PROTEIN","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"LEU A 608;ALA A 580;VAL A 602;MET A 585;LEU A 629","None","1.37A","1kt7A-3j97A:undetectable","1kt7A-3j97A:12.18"],["1RTS_A_D16A309_1","THYMIDYLATE SYNTHASE","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",4,"PHE A 140;LEU A 147;GLY A 146;PHE A 145","None","0.68A","1rtsA-3j97A:undetectable","1rtsA-3j97A:17.09"],["1UDU_A_CIAA1003_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"VAL A  60;ALA A  61;PHE A  62;LEU A  72;ILE A  74","None","1.28A","1uduA-3j97A:undetectable","1uduA-3j97A:19.62"],["1V54_C_CHDC3525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","1v54A-3j97H:2.9;1v54C-3j97H:5.0","1v54A-3j97H:19.26;1v54C-3j97H:19.54"],["1V54_P_CHDP4525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.22A","1v54N-3j97H:2.8;1v54P-3j97H:5.0","1v54N-3j97H:19.26;1v54P-3j97H:19.54"],["1V55_C_CHDC3525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","1v55A-3j97H:2.8;1v55C-3j97H:5.0","1v55A-3j97H:19.26;1v55C-3j97H:19.54"],["1WOP_A_FFOA2888_0","AMINOMETHYLTRANSFERASE","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"LEU A 541;LEU A 552;ILE A 665;GLU A 522;LEU A 518","None","1.25A","1wopA-3j97A:undetectable","1wopA-3j97A:20.51"],["2DYR_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","2dyrA-3j97H:2.8;2dyrC-3j97H:5.1","2dyrA-3j97H:19.26;2dyrC-3j97H:19.54"],["2DYR_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","2dyrN-3j97H:2.8;2dyrP-3j97H:5.0","2dyrN-3j97H:19.26;2dyrP-3j97H:19.54"],["2DYS_C_CHDC304_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.25A","2dysA-3j97H:2.7;2dysC-3j97H:5.1","2dysA-3j97H:19.26;2dysC-3j97H:19.54"],["2DYS_P_CHDP304_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.22A","2dysN-3j97H:2.7;2dysP-3j97H:5.1","2dysN-3j97H:19.26;2dysP-3j97H:19.54"],["2EIJ_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","2eijA-3j97H:2.8;2eijC-3j97H:5.0","2eijA-3j97H:19.26;2eijC-3j97H:19.54"],["2EIJ_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","2eijN-3j97H:2.8;2eijP-3j97H:5.0","2eijN-3j97H:19.26;2eijP-3j97H:19.54"],["2EIK_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.27A","2eikA-3j97H:undetectable;2eikC-3j97H:5.0","2eikA-3j97H:19.26;2eikC-3j97H:19.54"],["2EIK_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.23A","2eikN-3j97H:2.8;2eikP-3j97H:5.0","2eikN-3j97H:19.26;2eikP-3j97H:19.54"],["2EIL_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","2eilA-3j97H:2.7;2eilC-3j97H:5.0","2eilA-3j97H:19.26;2eilC-3j97H:19.54"],["2EIL_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.23A","2eilN-3j97H:2.8;2eilP-3j97H:5.0","2eilN-3j97H:19.26;2eilP-3j97H:19.54"],["2EIM_A_CHDA525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.25A","2eimA-3j97H:3.4;2eimC-3j97H:5.1","2eimA-3j97H:19.26;2eimC-3j97H:19.54"],["2EIM_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.30A","2eimN-3j97H:3.2;2eimP-3j97H:5.0","2eimN-3j97H:19.26;2eimP-3j97H:19.54"],["2EIN_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","2einA-3j97H:2.4;2einC-3j97H:5.0","2einA-3j97H:19.26;2einC-3j97H:19.54"],["2EIN_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.28A","2einN-3j97H:2.8;2einP-3j97H:5.1","2einN-3j97H:19.26;2einP-3j97H:19.54"],["2P2F_B_ACTB653_0","ACETYL-COENZYME A SYNTHETASE","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",4,"VAL A 350;THR A 349;VAL A 295;GLY A 296","None","1.12A","2p2fB-3j97A:undetectable","2p2fB-3j97A:21.97"],["2QEU_A_ACTA141_0","PUTATIVE CARBOXYMUCONOLACTONE DECARBOXYLASE","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",3,"VAL H 256;ASP H 257;GLU H 291","None","0.50A","2qeuA-3j97H:3.5","2qeuA-3j97H:19.18"],["2QEU_C_ACTC141_0","PUTATIVE CARBOXYMUCONOLACTONE DECARBOXYLASE","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",3,"VAL H 256;ASP H 257;GLU H 291","None","0.52A","2qeuC-3j97H:3.5","2qeuC-3j97H:19.18"],["2X91_A_LPRA1615_2","ANGIOTENSIN CONVERTING ENZYME","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",3,"SER A 569;THR A 550;PHE A 661","None","0.74A","2x91A-3j97A:undetectable","2x91A-3j97A:21.53"],["2XZ5_C_ACHC1210_0","SOLUBLE ACETYLCHOLINE RECEPTOR","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",4,"ILE A 643;TYR A 502;VAL A 602;CYH A 599","None","1.18A","2xz5A-3j97A:undetectable;2xz5C-3j97A:undetectable","2xz5A-3j97A:14.13;2xz5C-3j97A:14.13"],["2XZ5_D_ACHD1210_0","SOLUBLE ACETYLCHOLINE RECEPTOR","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",4,"ILE A 643;TYR A 502;VAL A 602;CYH A 599","None","1.17A","2xz5C-3j97A:undetectable;2xz5D-3j97A:undetectable","2xz5C-3j97A:14.13;2xz5D-3j97A:14.13"],["2XZ5_E_ACHE1210_0","SOLUBLE ACETYLCHOLINE RECEPTOR","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",4,"ILE A 643;TYR A 502;VAL A 602;CYH A 599","None","1.19A","2xz5D-3j97A:undetectable;2xz5E-3j97A:undetectable","2xz5D-3j97A:14.13;2xz5E-3j97A:14.13"],["2XZ5_E_ACHE1211_0","SOLUBLE ACETYLCHOLINE RECEPTOR","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"ILE H 125;SER H 157;TYR H 151;CYH H 164","None","1.29A","2xz5D-3j97H:undetectable;2xz5E-3j97H:undetectable","2xz5D-3j97H:21.23;2xz5E-3j97H:21.23"],["2Y69_A_CHDA1517_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","2y69A-3j97H:2.8;2y69C-3j97H:5.1","2y69A-3j97H:19.26;2y69C-3j97H:19.54"],["2ZXW_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.21A","2zxwA-3j97H:2.8;2zxwC-3j97H:5.0","2zxwA-3j97H:19.26;2zxwC-3j97H:19.54"],["2ZXW_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.22A","2zxwN-3j97H:3.7;2zxwP-3j97H:5.0","2zxwN-3j97H:19.26;2zxwP-3j97H:19.54"],["3ABK_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.23A","3abkA-3j97H:2.9;3abkC-3j97H:5.0","3abkA-3j97H:19.26;3abkC-3j97H:19.54"],["3ABK_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.27A","3abkN-3j97H:2.3;3abkP-3j97H:5.0","3abkN-3j97H:19.26;3abkP-3j97H:19.54"],["3ABM_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.22A","3abmN-3j97H:2.9;3abmP-3j97H:5.0","3abmN-3j97H:19.26;3abmP-3j97H:19.54"],["3AG1_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.27A","3ag1A-3j97H:3.2;3ag1C-3j97H:4.9","3ag1A-3j97H:19.26;3ag1C-3j97H:19.54"],["3AG1_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.26A","3ag1N-3j97H:2.7;3ag1P-3j97H:5.0","3ag1N-3j97H:19.26;3ag1P-3j97H:19.54"],["3AG2_A_CHDA525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.26A","3ag2A-3j97H:2.8;3ag2C-3j97H:5.0","3ag2A-3j97H:19.26;3ag2C-3j97H:19.54"],["3AG2_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.25A","3ag2N-3j97H:3.4;3ag2P-3j97H:5.0","3ag2N-3j97H:19.26;3ag2P-3j97H:19.54"],["3AG3_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.28A","3ag3A-3j97H:3.3;3ag3C-3j97H:5.0","3ag3A-3j97H:19.26;3ag3C-3j97H:19.54"],["3AG3_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","3ag3N-3j97H:2.8;3ag3P-3j97H:5.0","3ag3N-3j97H:19.26;3ag3P-3j97H:19.54"],["3AG4_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.26A","3ag4A-3j97H:undetectable;3ag4C-3j97H:5.0","3ag4A-3j97H:19.26;3ag4C-3j97H:19.54"],["3AG4_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.28A","3ag4N-3j97H:2.8;3ag4P-3j97H:5.0","3ag4N-3j97H:19.26;3ag4P-3j97H:19.54"],["3ASN_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.26A","3asnA-3j97H:2.9;3asnC-3j97H:5.0","3asnA-3j97H:19.26;3asnC-3j97H:19.54"],["3DXY_A_SAMA1_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",5,"GLU H 186;GLY H 189;ILE H 184;ALA H 169;ASP H 204","None","0.97A","3dxyA-3j97H:undetectable","3dxyA-3j97H:20.58"],["3J6G_B_TA1B502_1","TUBULIN BETA CHAIN","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"ASP A  14;LEU A 136;SER A 139;PHE A 125;THR A  48","None","1.49A","3j6gB-3j97A:undetectable","3j6gB-3j97A:20.21"],["3J6G_D_TA1D502_1","TUBULIN BETA CHAIN","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"ASP A  14;LEU A 136;SER A 139;PHE A 125;THR A  48","None","1.49A","3j6gD-3j97A:undetectable","3j6gD-3j97A:20.21"],["3J6G_F_TA1F502_1","TUBULIN BETA CHAIN","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"ASP A  14;LEU A 136;SER A 139;PHE A 125;THR A  48","None","1.49A","3j6gF-3j97A:undetectable","3j6gF-3j97A:20.21"],["3J6G_H_TA1H502_1","TUBULIN BETA CHAIN","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"ASP A  14;LEU A 136;SER A 139;PHE A 125;THR A  48","None","1.49A","3j6gH-3j97A:1.3","3j6gH-3j97A:20.21"],["3J6G_J_TA1J502_1","TUBULIN BETA CHAIN","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"ASP A  14;LEU A 136;SER A 139;PHE A 125;THR A  48","None","1.49A","3j6gJ-3j97A:1.8","3j6gJ-3j97A:20.21"],["3J6G_L_TA1L502_1","TUBULIN BETA CHAIN","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"ASP A  14;LEU A 136;SER A 139;PHE A 125;THR A  48","None","1.49A","3j6gL-3j97A:1.2","3j6gL-3j97A:20.21"],["3J6G_N_TA1N502_1","TUBULIN BETA CHAIN","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"ASP A  14;LEU A 136;SER A 139;PHE A 125;THR A  48","None","1.49A","3j6gN-3j97A:undetectable","3j6gN-3j97A:20.21"],["3J6G_P_TA1P502_1","TUBULIN BETA CHAIN","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"ASP A  14;LEU A 136;SER A 139;PHE A 125;THR A  48","None","1.49A","3j6gP-3j97A:1.2","3j6gP-3j97A:20.21"],["3J6G_R_TA1R502_1","TUBULIN BETA CHAIN","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"ASP A  14;LEU A 136;SER A 139;PHE A 125;THR A  48","None","1.49A","3j6gR-3j97A:undetectable","3j6gR-3j97A:20.21"],["3KK6_A_CELA701_2","PROSTAGLANDIN G\/H SYNTHASE 1","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",4,"VAL A 514;LEU A 641;ILE A 567;LEU A 518","None","0.72A","3kk6A-3j97A:undetectable","3kk6A-3j97A:20.70"],["3L35_H_DHIH3_0","GP41 N-PEPTIDE;HIV ENTRY INHIBITOR PIE12","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",3,"LEU A 710;TRP A 510;GLY A 511","None","0.76A","3l35A-3j97A:undetectable;3l35H-3j97A:undetectable","3l35A-3j97A:5.50;3l35H-3j97A:1.75"],["3L35_K_DHIK3_0","GP41 N-PEPTIDE;HIV ENTRY INHIBITOR PIE12","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",3,"LEU A 710;TRP A 510;GLY A 511","None","0.81A","3l35B-3j97A:undetectable;3l35K-3j97A:undetectable","3l35B-3j97A:5.50;3l35K-3j97A:1.75"],["3WG7_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.23A","3wg7C-3j97H:5.0;3wg7N-3j97H:2.8;3wg7P-3j97H:5.0","3wg7C-3j97H:19.54;3wg7N-3j97H:19.26;3wg7P-3j97H:19.54"],["4ECK_B_FOLB703_0","BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"ASP A 328;PHE A 327;LEU A 354;VAL A 369;THR A 267","None","0.91A","4eckB-3j97A:undetectable","4eckB-3j97A:23.62"],["4IAR_A_ERMA2001_2","CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 1B AND E. COLI SOLUBLE CYTOCHROME B562","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",4,"THR A 534;VAL A 628;SER A 662;ASP A 590","None","1.29A","4iarA-3j97A:undetectable","4iarA-3j97A:20.78"],["5B1A_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.23A","5b1aN-3j97H:2.8;5b1aP-3j97H:5.0","5b1aN-3j97H:19.26;5b1aP-3j97H:19.54"],["5B1B_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.25A","5b1bN-3j97H:3.6;5b1bP-3j97H:5.1","5b1bN-3j97H:19.26;5b1bP-3j97H:19.54"],["5B3S_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","5b3sN-3j97H:2.8;5b3sP-3j97H:5.0","5b3sN-3j97H:19.26;5b3sP-3j97H:19.54"],["5H3A_B_D16B401_1","ORF70","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",4,"PHE A 140;LEU A 147;GLY A 146;PHE A 145","None","0.64A","5h3aB-3j97A:undetectable","5h3aB-3j97A:16.74"],["5IY5_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.20A","5iy5A-3j97H:2.8;5iy5C-3j97H:5.0","5iy5A-3j97H:19.26;5iy5C-3j97H:18.85"],["5J4N_B_AG2B501_1","ARGININE\/AGMATINE ANTIPORTER","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"ILE H 125;GLY H  89;ASN H  90;ILE H 127","None","0.95A","5j4nB-3j97H:undetectable","5j4nB-3j97H:19.43"],["5KOC_A_SAMA401_0","PAVINE N-METHYLTRANSFERASE","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"GLY A 543;VAL A 517;THR A 515;ALA A 551;LEU A 552","None","1.04A","5kocA-3j97A:2.2","5kocA-3j97A:20.14"],["5NVP_A_ACAA18_1","ENVELOPE GLYCOPROTEIN,GP41","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",5,"SER H 238;LYS H 242;LYS H 203;GLU H 229;GLU H 230","None","1.45A","5nvpA-3j97H:0.0","5nvpA-3j97H:7.74"],["5TZO_B_7V7B201_1","ENDO-1,4-BETA-XYLANASE A","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",5,"LEU A  16;SER A  25;VAL A  23;ALA A   9;ALA A  61","None","1.16A","5tzoB-3j97A:undetectable","5tzoB-3j97A:12.05"],["5X19_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","5x19N-3j97H:0.7;5x19P-3j97H:4.9","5x19N-3j97H:19.26;5x19P-3j97H:19.54"],["5X1B_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.21A","5x1bN-3j97H:2.7;5x1bP-3j97H:4.8","5x1bN-3j97H:19.26;5x1bP-3j97H:19.54"],["5X1F_P_CHDP305_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.25A","5x1fN-3j97H:2.8;5x1fP-3j97H:4.9","5x1fN-3j97H:19.26;5x1fP-3j97H:19.54"],["5X5Q_C_D16C402_1","THYMIDYLATE SYNTHASE","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",4,"PHE A 140;LEU A 147;GLY A 146;PHE A 145","None","0.62A","5x5qC-3j97A:undetectable","5x5qC-3j97A:17.12"],["5X5Q_D_D16D402_1","THYMIDYLATE SYNTHASE","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",4,"PHE A 140;LEU A 147;GLY A 146;PHE A 145","None","0.64A","5x5qD-3j97A:undetectable","5x5qD-3j97A:17.12"],["5X5Q_F_D16F402_1","THYMIDYLATE SYNTHASE","3j97","VESICLE-FUSING ATPASE","Cricetulus griseus",4,"PHE A 140;LEU A 147;GLY A 146;PHE A 145","None","0.63A","5x5qF-3j97A:undetectable","5x5qF-3j97A:17.12"],["5Z84_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.22A","5z84A-3j97H:2.8;5z84C-3j97H:5.1;5z84P-3j97H:5.1","5z84A-3j97H:19.26;5z84C-3j97H:19.54;5z84P-3j97H:19.54"],["5Z84_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.22A","5z84C-3j97H:5.1;5z84N-3j97H:2.8;5z84P-3j97H:5.1","5z84C-3j97H:19.54;5z84N-3j97H:19.26;5z84P-3j97H:19.54"],["5Z85_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","5z85C-3j97H:5.0;5z85N-3j97H:2.9;5z85P-3j97H:5.1","5z85C-3j97H:19.54;5z85N-3j97H:19.26;5z85P-3j97H:19.54"],["5ZCO_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.23A","5zcoA-3j97H:2.8;5zcoC-3j97H:5.1;5zcoP-3j97H:5.1","5zcoA-3j97H:19.26;5zcoC-3j97H:19.54;5zcoP-3j97H:19.54"],["5ZCQ_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.23A","5zcqN-3j97H:2.8;5zcqP-3j97H:5.1","5zcqN-3j97H:19.26;5zcqP-3j97H:19.54"],["6MN4_B_AM2B301_0","AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE, AAC(3)-IVA","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"ASP H  80;HIS H 123;HIS H  72;ASP H  87","None","1.11A","6mn4B-3j97H:undetectable","6mn4B-3j97H:20.06"],["6MN4_C_AM2C301_0","AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE, AAC(3)-IVA","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"ASP H  80;HIS H 123;HIS H  72;ASP H  87","None","1.07A","6mn4C-3j97H:undetectable","6mn4C-3j97H:20.06"],["6NKN_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.23A","6nknA-3j97H:2.9;6nknC-3j97H:4.8","6nknA-3j97H:19.26;6nknC-3j97H:19.54"],["6NMF_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","6nmfN-3j97H:undetectable;6nmfP-3j97H:4.9","6nmfN-3j97H:19.26;6nmfP-3j97H:19.54"],["6NMP_C_CHDC303_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.21A","6nmpA-3j97H:2.8;6nmpC-3j97H:4.8","6nmpA-3j97H:19.26;6nmpC-3j97H:19.54"],["6NMP_P_CHDP302_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3j97","ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN","Rattus norvegicus",4,"HIS H 124;ASP H 113;THR H 112;HIS H 144","None","1.24A","6nmpN-3j97H:1.6;6nmpP-3j97H:5.0","6nmpN-3j97H:19.26;6nmpP-3j97H:19.54"]]